Endotypes and Phenotypes in ILD: Is It Time to Reclassify ILD by Risk Stratification?

Interstitial lung diseases (ILD) comprise a heterogeneous group of disorders that present significant challenges in both diagnosis and management due to their varied nature, which encompasses different degrees of inflammation and fibrosis affecting lung tissue [...]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicines Jg. 13; H. 7; S. 1529
Hauptverfasser: Amati, Francesco, Stainer, Anna, Aliberti, Stefano
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Switzerland MDPI AG 23.06.2025
MDPI
Schlagworte:
Biomarkers
Cancer therapies
Care and treatment
Clinical medicine
Clinical practice guidelines
Clinical trials
Connective tissue diseases
Development and progression
Evidence-based medicine
Genetic aspects
Lung cancer
Lung diseases
Magnetic resonance imaging
Medical prognosis
Medical research
Medicine, Experimental
n/a
Patients
Phenotype
Phenotypes
Precision medicine
Pulmonary fibrosis
Sarcoidosis
ISSN:2227-9059, 2227-9059
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Interstitial lung diseases (ILD) comprise a heterogeneous group of disorders that present significant challenges in both diagnosis and management due to their varied nature, which encompasses different degrees of inflammation and fibrosis affecting lung tissue [...]
Bibliographie:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines13071529